A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2019
At a glance
- Drugs Tadalafil (Primary)
- Indications Head and neck cancer
- Focus Biomarker; Pharmacodynamics
- 11 Jan 2019 Planned End Date changed from 1 Sep 2016 to 1 Dec 2019.
- 11 Jan 2019 Planned primary completion date changed from 1 Sep 2014 to 1 Dec 2019.
- 11 Jan 2019 Status changed from recruiting to active, no longer recruiting.